Aug 28 (Reuters) - Avecho Biotechnology Ltd (AVE) :
- AVECHO BIOTECHNOLOGY LTD - AVECHO CONDUCTS A$6M PLACEMENT TO ADVANCE PHASE III CLINCIAL TRIAL
- AVECHO BIOTECHNOLOGY - PLACEMENT VIA INITIAL ISSUE OF 536.8 MILLION FULLY PAID ORDINARY SHARES
- AVECHO BIOTECHNOLOGY LTD - PLACEMENT AT AN ISSUE PRICE OF A$0.006 PER NEW SHARE
- Forums
- ASX - By Stock
- AVE
- News: AVE Avecho Biotechnology Says Avecho Conducts A$6M Placement
News: AVE Avecho Biotechnology Says Avecho Conducts A$6M Placement
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.035K | 678.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39213222 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 40284733 | 0.002 |
32 | 75717741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39213222 | 29 |
0.004 | 30014232 | 16 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 13.19pm 13/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online